Indomethacin is a non-steroidal anti-inflammatory drug (NSAID) (1). Indole, the potent basic pharmacodynamic nucleus, has been reported to possess a wide variety of biological properties, viz. anti-inflammatory (2-4), analgesic (5), anticonvulsant (6, 7) antibacterial and antifungal (8, 9). On the other hand, novel pyrazolo(3,4-b)indole nucleoside analogs have been synthesized from the corresponding 3-formyl-2-chloro and 3-cyano-2-chloro indole nucleosides by treatment with hydrazine hydrate (10) and they acted as potent and selective inhibitors of human cytomegalovirus (HCMV) in vitro (10). Moreover, when p-nitrophenylhydrazones of several acetophenones, benzaldehydes and benzophenones were treated with polyphosphoric acid (PPA) new substances containing the original nitrogen atoms were isolated from the reaction and were characterized as nitrophenylindazoles (11). Encouraged by these observations, we synthesized novel pyrazolo(3,4-b) indole derivatives and evaluated their anti-inflammatory, analgesic as well as anticonvulsant activities in the hope of obtaining superior pharmacological agents. 1,8-dihydro-1-aryl-8-alkyl pyrazolo(3,4-b A series of 1,8-dihydro-1-aryl-8-alkyl pyrazolo(3,4-b)indoles 4a-j, 5a-j and 6a-j has been synthesized and tested for their anti-inflammatory and anticonvulsant activities. Formation of the pyrazoloindole derivatives was achieved by treating arylhydrazones of N-alkyl indole-3-carboxaldehydes 1a-j, 2a-j and 3a-j with ten times their mass of polyphosphoric acid as a condensing agent. The newly synthesized compounds were evaluated for their anti-inflammatory, analgesic and anticonvulsant activities compared to indomethacin, flufenamic acid and diazepam as positive controls. Detailed synthesis, spectroscopic and toxicity data are reported.
Anti-inflammatory activity. -The inhibitory activity of the studied compounds on carrageenean-induced rat's paw edema was determined according to the method of Obkowicz et al. (14) . Groups of adult male albino rats, 8 animals each, were orally dosed with tested compounds at doses of 100, 50, 25 and 5 mg kg -1 one hour before carrageenean challenge. Foot paw edema was induced by subplantar injection of 0.05 mL of 1 % suspension of carrageenean in saline into the plantar tissue of one hind paw. An equal volume of saline was injected into the other hind paw and served as a control. The animals were decapitated four hours after drug administration.
The average mass of edema was estimated for the treated as well as for the control group and the percentage inhibition of edema was evaluated (15) . Indomethacin (5.0 mg kg -1 ), suspended in saline, was employed as a reference drug against the test compounds. Data are expressed as mean ± SEM. The results of carrageenean-induced paw edema are expressed as percentage of change from the control (pre-drug) values. Differences between the vehicle control and treatment groups were tested using one-way ANOVA followed by multiple comparisons by Duncan's multiple range tests.
Analgesic activity. -The method of Okun et al. (16) was used to induce writhing. The test compounds and the reference drugs flufenamic acid and indomethacine were prepared as a suspension in 2 % Tween 80. A sensitivity test was carried out one day before drug administration when the animals were injected (i.p.) with 0.2-0.25 mL of 0.02 % freshly prepared solution of p-benzoquinone in distilled water. Animals showing writhing to p-benzoquinone within 30 minutes were chosen for studying the analgesic activity. On the following day, mice were divided into 13 groups of 6 animals each. The drugs were administered orally according to the following protocol: one group received 2 % Tween 80 (solvent and negative control), the second group received flufenamic acid as reference (20 mg kg -1 ), and the third group received indomethacine (5 mg kg -1 ), while the other groups received doses of the tested compounds 100, 50, 25 and 5 mg kg -1 . One hour latter, 0.02 % solution of p-benzoquinone was administered (i.p.). The animals were observed for 30 minutes after injection of the irritant, during which time the animals showing writhing were counted (writhing is defined as stretch, torsion to one side, drawing up of hind leg, retraction of the abdomen, so that the belly touches the floor). All writhing is considered as a positive response. The analgesic activity was expressed as the percent protection. Anticonvulsant activity. -Mice of both sexes weighing 20-25 g were used and injected intraperitoneally with 2 % Tween 80 (control) and 5 mg kg -1 diazepam (reference drug). Other groups received tested components at doses 5, 25 and 50 mg kg -1 . One hour after the drug administration, animals were stimulated through an ear electrode of 50 mA as a signal stimulator for 0.2 s (17). Characteristic of an electric shock seizure are a tonic limb flexion for 1 to 2 s, followed by a tonic limb extension for roughly 10 to 12 s, and finally generalized clonic movement for 12 s. Only abolishment of the hind limb tonic extensor spasm is recorded as the measure of anticonvulsant potency. The tonic component is considered abolished if the hind leg extension does not exceed a 90°angle with the plane of the body. Animals showing protection against convulsion were counted in each group. The anticonvulsant activity was expressed as the percent protection.
RESULTS AND DISCUSSION
The starting materials, arylhydrazones 1-3 were prepared through the condensation reaction of N-alkylindole-3-carboxaldehydes with substituted phenylhydrazines in refluxing absolute ethanol.
The structure of the new arylhydrazones 1-3 was confirmed based on their precise elemental analyses (Table I ) and spectroscopic data (Table II) . The 1 H NMR spectra of the latter compounds revealed singlet signals at 8.5-8.75 ppm for CH=N and singlet signals from 7.9 to 8.2 ppm for H-2 of indole nucleus, besides other signals (Table II) (Table I) , IR, 1 H NMR and mass spectral data (Table II) .
There is no doubt about the proposed structure of the new target compounds pyrazoloindoles 4-6. First, the absence of NH absorption bands in the IR spectra of compounds 4-6 which appeared in the starting ones 1-3. Second, their 1 H NMR spectra lack the singlet signals at d 7.9-8.2 ppm of H-2 indole nucleus and singlet signals of the anilic protons, and revealed new singlet signals at d 7.6-7.8 ppm of the pyrazole ring. This is a good evidence for the proposed structures 4-6. For example, the IR spectrum of compound 4c showed absorption bands at 1620 (C=N) and 1600 cm -1 (C=C). Its 1 H NMR spectrum revealed signals at d 7.71 (s, 1H, H-pyrazole), 7.0-7.56 (m, 9H, Ar-H), 4.0 (q, 2H, CH 2 ) and 1.6 ppm (t, 3H, CH 3 ). Its mass spectrum is in accordance with the proposed structure, which showed a molecular ion peak at m/z = 261 (65 %) and a base peak at m/z = 105 (100 %) besides the other fragments, as illustrated in Table II . The physical and analytical data of the target compounds 4-6 are given in Table I and the spectroscopic data in Table II . The newly synthesized compounds 4-6 were evaluated for their anti-inflammatory activity against carrageenean induced rat's paw oedema by administration of 100, 50, 25 and 5 mg kg -1 (p.o.) using indomethacin as a reference drug (5 mg kg -1 ). None of the tested compounds showed antiinflammatory activity at doses of 3 and 5 mg kg -1 , whereas compounds 4e, 4f, 4g, 4j, 5d, 5g, 6d, 6f, 6g and 6j exhibited remarkable anti-inflammatory activity ranging from 30 to 65 % at a dose of 50 mg kg -1 and from 54 to 78 % at a dose of 100 mg kg -1 . The results of the tested compounds are given in (Table III) . Higher anti-inflammatory activity of the previously mentioned compounds compared to the others may be due to the presence of the halo atoms in their skeletons. The most potent compounds were 6g and 4g with anti-inflammatory activity of 85 and 79 % at a dose of 100 mg kg -1 and 70 and 64 % at a dose of 50 mg kg -1 , respectively.
None of the tested components showed analgesic activity at doses of 25 and 5 mg kg -1 , but the chosen compounds showed remarkable analgesic activity at a dose of 100 mg kg -1 (Table IV) . Compounds 4e, 4f, 4g, 4j, 6d, 6f, 6g and 6j showed higher activity at a dose of 100 mg kg -1 than the reference drug flufenamic acid at a dose of 20 mg kg -1 . The protection of these compounds ranged from 66 to 100 %, while compounds 4f and 6f, at a dose of 50 mg kg -1 , showed the same analgesic activity as the reference drug flufenamic acid. From the data in Table IV it is clear that only compounds 6f and 6g showed high analgesic activity at a dose of 50 mg kg -1 of 67 and 83 %, while at a dose of 25 mg kg -1 they showed 33 and 50 % protection.
Compounds 4-6 exhibited remarkable anticonvulsant activity (Table V) . Compounds 4f, 4g, 5f, 5g, 5j, 6f, 6g and 6j at a dose of 50 mg kg -1 showed anticonvulsant activity higher than that of diazepam at 5 mg kg -1 . On the other hand, compounds 4f, 4g, 5f, 5g, 6f and 6g at a dose of 25 mg kg -1 showed 50 % anticonvulsant protection as did the reference drug diazepam at 5 mg kg -1 . None among the tested compounds showed anticonvulsant activity at a dose of 5 mg kg -1 .
CONCLUSIONS
The newly synthesized compounds 1,8-dihydro-1-aryl-8-alkyl pyrazolo(3,4-b)indoles 4, 5 and 6a-j showed remarkable anti-inflammatory, analgesic and anticonvulsant activities. The presence of the halogen atoms in their skeletons seem to be essential for these activities.
